-53.6%
BSX vs MRNA
+945.0%
-998.7%
-60.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.3% | +13.1% | -7.8% | +5.0% |
| 7D | +8.0% | +20.6% | -12.7% | +7.5% |
| 30D | +8.1% | +27.1% | -19.1% | +7.2% |
| 3M | -6.7% | +353.4% | -360.0% | -11.2% |
| 6M | -19.4% | +446.3% | -465.7% | -23.9% |
| YTD | -51.9% | +776.2% | -828.1% | -55.7% |
| 1Y | -53.6% | +987.9% | -1,041.6% | -58.3% |
| All | -53.6% | +945.0% | -998.7% | -58.3% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling